By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Dyadic today announced it has raised $3 million through a private placement of convertible subordinated secured promissory notes to five undisclosed investors.

The Jupiter, Fla.-based firm expects to use proceeds from the funding for working capital, including investments in R&D, new product launches, and general corporate purposes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.